April 1 (Reuters) - Medibio Ltd MEB.AX :
* Announce a positive pre-submission meeting with the United States food and drug administration (FDA) on its proposed diagnostic for depression
* It confirmed the proposed regulatory pathway of medibio's depression test with the FDA
* Source text for Eikon ID:nASX1PvRFn
*